Azathioprine, 6-mercaptopurine and thiopurine s-methyltransferase levels in inflammatory bowel disease: what is current clinical practice?

被引：0
|
作者：
Siriwardana, A. S. [1 ]
Koo, J. H. [1 ,2 ]
Ng, W. S. W. [1 ,2 ]
Connor, S. J. [1 ,2 ]
机构：
[1] Univ New S Wales, Sydney, NSW 2052, Australia
[2] Liverpool Hosp, Dept Gastroenterol, Liverpool, Merseyside, England
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A311 / A312
页数：2
相关论文
共 50 条
  • [1] Azathioprine, 6-mercaptopurine and thiopurine S-methyltransferase
    Roberts-Thomson, C
    Butler, WJ
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (06) : 955 - 955
  • [2] Azathioprine, 6-mercaptopurine and thiopurine s-methyltransferase levels in gastroenterology and rheumatology: a comparison of clinical practice in Australia
    Siriwardana, A. S.
    Koo, J. H.
    Ng, W. S. W.
    Connor, S. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A222 - A223
  • [3] Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease
    Kader, HA
    Wenner, WJ
    Telega, GW
    Maller, ES
    Baldassano, RN
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2000, 30 (04) : 409 - 413
  • [4] Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
    Gisbert, JP
    Luma, M
    Maté, J
    González-Guijarro, L
    Cara, C
    Pajares, JM
    MEDICINA CLINICA, 2003, 121 (01): : 1 - 5
  • [5] Adverse Reactions of Azathioprine/6-Mercaptopurine Treatment, Thiopurine S-Methyltransferase and Inosine Triphosphate Pyrophosphohydrolase Genes in Japanese Patients with Inflammatory Bowel Disease
    Uchiyama, Kan
    Kubota, Takahiro
    Odahara, Shunichi
    Koido, Shigeo
    Yamane, Tateki
    Ohkusa, Toshifumi
    Tajiri, Hisao
    GASTROENTEROLOGY, 2009, 136 (05) : A208 - A208
  • [6] Treatment regimens of azathioprine or 6-mercaptopurine in Inflammatory bowel disease in clinical practice
    van Marrewijk, C. J.
    Franke, B.
    Coenen, M. J. H.
    Derrijks, L. J. J.
    Guchelaar, H. J.
    Klungel, O. H.
    Marle, M. E. v. d. Akker-V.
    Verbeek, A. L. M.
    Vermeulen, H. M. M.
    Scheffer, H.
    de Jong, D. J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (03) : A33 - A33
  • [7] Dosing azathioprine in thiopurine S-methyltransferase deficient inflammatory bowel disease patients
    Derijks, L. J. J.
    van Helden, R. B.
    Hommes, D. W.
    Stokkers, P. C.
    GUT, 2008, 57 (06) : 872 - 872
  • [8] Safety of azathioprine and 6-mercaptopurine in patients with inflammatory bowel disease naive to thiopurine treatment
    Alaish, Ram
    Lundgren, David
    Suhr, Ole B.
    Werner, Marten
    Karling, Pontus
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (07) : 594 - 600
  • [9] Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine/6-mercaptopurine treatment
    Kan Uchiyama
    Makoto Nakamura
    Takahiro Kubota
    Tateki Yamane
    Kiyotaka Fujise
    Hisao Tajiri
    Journal of Gastroenterology, 2009, 44
  • [10] AZATHIOPRINE, 6-MERCAPTOPURINE, AND INFLAMMATORY BOWEL-DISEASE
    BEAUGERIE, L
    GENDRE, JP
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1990, 14 (03): : 230 - 240
12345